This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Genentech, Inc.. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: Frederic S Jacobson: Innovator in Antibody-Drug Conjugates
Introduction
Frederic S Jacobson is a notable inventor based in Berkeley, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. With a total of 2 patents, Jacobson's work is pivotal in advancing cancer treatment methodologies.
Latest Patents
Jacobson's latest patents focus on antibody-drug conjugate compounds. The first patent describes compounds of the formula I: Ab-(L-D), where one or more maytansinoid drug moieties (D) are covalently linked by L to an antibody (Ab) that binds to an ErbB receptor or tumor-associated antigens. These compounds are designed for use in diagnosing or treating cancer and other diseases.
Career Highlights
Frederic S Jacobson is currently associated with Genentech, Inc., a leading biotechnology company. His work at Genentech has been instrumental in the development of innovative therapies that target cancer cells more effectively.
Collaborations
Jacobson has collaborated with esteemed colleagues such as Allen J Ebens and Paul Polakis. These partnerships have fostered a collaborative environment that enhances research and development in the field of antibody-drug conjugates.
Conclusion
Frederic S Jacobson's contributions to biotechnology, particularly in antibody-drug conjugates, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and diagnosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile